Private Trust Company’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$543K Buy
1,405
+73
+5% +$27.1K 0.04% 443
2026
Q1
$390K Sell
1,332
-80
-6% -$26.3K 0.03% 521
2025
Q4
$495K Sell
1,412
-127
-8% -$42.9K 0.04% 440
2025
Q3
$497K Sell
1,539
-75
-5% -$23.3K 0.04% 425
2025
Q2
$628K Sell
1,614
-16
-1% -$6.44K 0.06% 352
2025
Q1
$709K Buy
1,630
+22
+1% +$8.83K 0.07% 293
2024
Q4
$593K Sell
1,608
-20
-1% -$8.37K 0.06% 329
2024
Q3
$846K Sell
1,628
-19
-1% -$10.2K 0.09% 256
2024
Q2
$892K Buy
1,647
+145
+10% +$76.6K 0.1% 236
2024
Q1
$779K Buy
1,502
+65
+5% +$32.3K 0.08% 263
2023
Q4
$677K Sell
1,437
-35
-2% -$16.2K 0.08% 271
2023
Q3
$641K Sell
1,472
-24
-2% -$10.9K 0.08% 266
2023
Q2
$664K Buy
1,496
+101
+7% +$46.6K 0.08% 267
2023
Q1
$641K Sell
1,395
-67
-5% -$31.9K 0.09% 263
2022
Q4
$750K Sell
1,462
-43
-3% -$21.8K 0.11% 217
2022
Q3
$683K Buy
1,505
+99
+7% +$47.4K 0.11% 214
2022
Q2
$678K Buy
+1,406
New +$696K 0.11% 226
2014
Q4
Sell
-181
Closed -$22K 540
2014
Q3
$22K Buy
181
+81
+81% +$9.29K 0.01% 810
2014
Q2
$11K Hold
100
﹤0.01% 1049
2014
Q1
$10K Hold
100
﹤0.01% 969
2013
Q4
$9K Hold
100
﹤0.01% 982
2013
Q3
$8K Hold
100
﹤0.01% 989
2013
Q2
$8K Buy
+100
New +$7.48K ﹤0.01% 919

Other funds holding ELV

Private Trust Company's ELV Position: Q2 2026 in Review

Private Trust Company increased its Elevance Health (ELV) stake by 5.5% in Q2 2026, buying an estimated $27.1K and bringing the position to 1,405 shares worth $543K. The position accounts for 0.04% of the portfolio, ranked #443.

Private Trust Company first reported a position in ELV in Q2 2013 and has held it in 23 quarters since. The position peaked at $892K in Q2 2024. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Private Trust Company held 1,405 shares of Elevance Health worth $543K as of Q2 2026.
  • Private Trust Company bought 73 Elevance Health shares in Q2 2026, an estimated $27.1K.
  • Elevance Health made up 0.04% of Private Trust Company's portfolio in Q2 2026, its #443 holding.
  • Private Trust Company first reported a position in Elevance Health in Q2 2013 and has held it in 23 quarters since.
  • Private Trust Company's Elevance Health position peaked at $892K in Q2 2024.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.